Company
Theravectys S.A.
Theravectys S.A. has 1 drug tracked on RxWires: 1 in Phase 1/2.
Pipeline
| Drug | Phase | Indication |
|---|---|---|
| Two IM injections Lenti-HPV-07 | Phase 1/2 | HPV-Related Cervical Carcinoma |
Latest
No recent events.
Follow Theravectys S.A. on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.